Home › Funds › Foresite Capital Management IV, LLC › EIKN

Foresite Capital Management IV, LLC position in EIKN

EIKON THERAPEUTICS INC · Health Care

Foresite Capital Management IV, LLC reported holding 1,943,682 shares of EIKN (EIKON THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$25.4M, representing 8.74% of its reported portfolio and ranking #3 among its reported holdings. Foresite Capital Management IV, LLC has disclosed EIKN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.94M sh
Reported value held$25.37M
Portfolio Weight8.74%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management IV, LLC's EIKN position evolved

Foresite Capital Management IV, LLC first disclosed a stake in EIKN in Q1 2026 at 1,943,682 shares (US$20.6M). The position peaked in Q2 2026 at 1,943,682 shares, worth US$25.4M. Across 2 filings, Foresite Capital Management IV, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,943,682 shares valued at US$25.4M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.94M $20.56M New
Q2 2026 1.94M $25.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EIKN and 13F data

EIKN (EIKON THERAPEUTICS INC) is a Health Care company. 88 other funds we track also report a position in EIKN — the largest reported positions include Merck & Co., Inc. (US$21.7M), Foresite Capital Management V, LLC (US$17.2M), EcoR1 Capital, LLC (US$9.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EIKN

All EIKN fund holders →

FAQ

How long has Foresite Capital Management IV, LLC held EIKN?

Foresite Capital Management IV, LLC has disclosed EIKN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Foresite Capital Management IV, LLC's current position in EIKN?

As of Q2 2026, Foresite Capital Management IV, LLC holds 1.94M shares of EIKN (EIKON THERAPEUTICS INC), valued at $25.37M, representing 8.74% of its reported portfolio and ranking #3.

Has Foresite Capital Management IV, LLC been buying or selling EIKN?

In the latest 13F filing (Q2 2026), Foresite Capital Management IV, LLC held unchanged its position in EIKN. The position peaked in Q2 2026 at 1.94M shares.

Which other funds hold EIKN?

Other major institutional holders of EIKN include Merck & Co., Inc., Foresite Capital Management V, LLC, EcoR1 Capital, LLC, among 88 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.